The ICOS-ICOSL pathway tunes thymic selection

Immunol Cell Biol. 2022 Mar;100(3):205-217. doi: 10.1111/imcb.12520. Epub 2022 Jan 23.

Abstract

Negative selection of developing T cells plays a significant role in T-cell tolerance to self-antigen. This process relies on thymic antigen-presenting cells which express both self-antigens and cosignaling molecules. Inducible T-cell costimulator (ICOS) belongs to the CD28 family of cosignaling molecules and binds to ICOS ligand (ICOSL). The ICOS signaling pathway plays important roles in shaping the immune response to infections, but its role in central tolerance is less well understood. Here we show that ICOSL is expressed by subsets of thymic dendritic cells and medullary thymic epithelial cells as well as thymic B cells. ICOS expression is upregulated as T cells mature in the thymus and correlates with T-cell receptor signal strength during thymic selection. We also provide evidence of a role for ICOS signaling in mediating negative selection. Our findings suggest that ICOS may fine-tune T-cell receptor signals during thymic selection contributing to the generation of a tolerant T-cell population.

Keywords: ICOS; ICOSL; negative selection; thymic antigen-presenting cells; thymocytes.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antigen-Presenting Cells* / metabolism
  • B-Lymphocytes / metabolism
  • CD28 Antigens / metabolism
  • Inducible T-Cell Co-Stimulator Ligand / metabolism
  • T-Lymphocytes*

Substances

  • CD28 Antigens
  • Inducible T-Cell Co-Stimulator Ligand